Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2295

1.

Drugs for Lupus While Breastfeeding.

Anderson PO.

Breastfeed Med. 2019 Oct 16. doi: 10.1089/bfm.2019.0232. [Epub ahead of print] No abstract available.

PMID:
31618050
2.

Corrigendum to Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/lpr lupus mice.

[No authors listed]

Lupus. 2019 Oct 16:961203319883488. doi: 10.1177/0961203319883488. [Epub ahead of print] No abstract available.

PMID:
31617825
3.

Increased expression of hub gene CXCL10 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.

Zhang R, Li Y, Pan B, Li Y, Liu A, Li X.

Exp Ther Med. 2019 Nov;18(5):4067-4075. doi: 10.3892/etm.2019.8013. Epub 2019 Sep 17.

PMID:
31616519
4.

Rapid induction of clinical remission by immunoadsorption for refractory lupus retinopathy complicated with life-threatening neuropsychiatric lupus.

Zhang G, Zhang X, Chai Y, Zang S, Shi Y, Wu H.

Ann Rheum Dis. 2019 Oct 15. pii: annrheumdis-2019-215930. doi: 10.1136/annrheumdis-2019-215930. [Epub ahead of print] No abstract available.

PMID:
31615755
5.

Complete heart block in lupus.

Natsheh A, Shimony D, Bogot N, Nesher G, Breuer GS.

Lupus. 2019 Oct 15:961203319881198. doi: 10.1177/0961203319881198. [Epub ahead of print]

PMID:
31615326
6.

Effect of air pollution on hospital admissions for systemic lupus erythematosus in Bengbu, China: a time series study.

Zhao CN, Mei YJ, Wu GC, Mao YM, Wu Q, Dan YL, Pan HF.

Lupus. 2019 Oct 15:961203319882503. doi: 10.1177/0961203319882503. [Epub ahead of print]

PMID:
31615325
7.

IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis.

Rose A, von Spee-Mayer C, Kloke L, Wu K, Kühl A, Enghard P, Burmester GR, Riemekasten G, Humrich JY.

Cells. 2019 Oct 11;8(10). pii: E1234. doi: 10.3390/cells8101234.

8.

Lymphopenia and neutropenia are associated with subsequent incident proteinuria in Danish patients with systemic lupus erythematosus.

Tanha N, Hansen RB, Yang J, Lange T, Nielsen CT, Helleberg M, Kamper AL, Faurschou M, Jacobsen S.

Scand J Rheumatol. 2019 Oct 15:1-9. doi: 10.1080/03009742.2019.1650107. [Epub ahead of print]

PMID:
31612777
9.

Lung cancer mimicking systemic lupus erythematosus: case-based review.

Liu J, Hu S, Niu M, Wang H, Wang Y, Tang N, Liu B.

Rheumatol Int. 2019 Oct 14. doi: 10.1007/s00296-019-04356-y. [Epub ahead of print] Review.

PMID:
31612248
10.

Toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus associated with lung carcinoma.

Santiago L, Mascarenhas R, Tellechea Ó, Gonçalo M.

BMJ Case Rep. 2019 Oct 13;12(10). pii: e231152. doi: 10.1136/bcr-2019-231152.

PMID:
31611227
11.

Bone health in patients with systemic lupus erythematosus.

Lai SW, Kuo YH, Liao KF.

Ann Rheum Dis. 2019 Oct 14. pii: annrheumdis-2019-216417. doi: 10.1136/annrheumdis-2019-216417. [Epub ahead of print] No abstract available.

PMID:
31611219
12.

Successful treatment of systemic lupus erythematosus-related refractory autoimmune hemolytic anemia with ofatumumab.

Poulet A, Jarrot PA, Mazodier K, Jean R, Kaplanski G.

Lupus. 2019 Oct 14:961203319881500. doi: 10.1177/0961203319881500. [Epub ahead of print] No abstract available.

PMID:
31610746
13.

Histopathology of catastrophic antiphospholipid syndrome-associated nephropathy in a SLE patient without concurrent lupus nephritis.

Gupta RK, Liu E, Bonilla E, Elsaid H.

Arthritis Rheumatol. 2019 Oct 14. doi: 10.1002/art.41136. [Epub ahead of print]

PMID:
31609535
14.

Economic evaluation of damage accrual in an international SLE inception cohort using a multi-state model approach.

Barber MRW, Hanly JG, Su L, Urowitz MB, St Pierre Y, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin PR, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Farewell V, Stoll T, Buyon J, Clarke AE.

Arthritis Care Res (Hoboken). 2019 Oct 14. doi: 10.1002/acr.24092. [Epub ahead of print]

PMID:
31609532
15.

Hsa_circ_0000479 as a Novel Diagnostic Biomarker of Systemic Lupus Erythematosus.

Guo G, Wang H, Ye L, Shi X, Yan K, Lin K, Huang Q, Li B, Lin Q, Zhu L, Xue X, Zhang H.

Front Immunol. 2019 Sep 24;10:2281. doi: 10.3389/fimmu.2019.02281. eCollection 2019.

16.

MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654.

Tu Y, Guo R, Li J, Wang S, Leng L, Deng J, Bucala R, Lu L.

Front Immunol. 2019 Sep 19;10:2229. doi: 10.3389/fimmu.2019.02229. eCollection 2019.

17.

Author Correction: Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways.

Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabothu S, Izmirly P, Clancy R, Belmont HM, Koenigsberg M, Mokrzycki M, Rominieki H, Graham JA, Rocca JP, Bornkamp N, Jordan N, Schulte E, Wu M, Pullman J, Slowikowski K, Raychaudhuri S, Guthridge J, James J, Buyon J, Tuschl T, Putterman C; Accelerating Medicines Partnership Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Consortium.

Nat Immunol. 2019 Oct 11. doi: 10.1038/s41590-019-0529-4. [Epub ahead of print]

PMID:
31605099
18.

Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus.

Xu J, Chen J, Li W, Lian W, Huang J, Lai B, Li L, Huang Z.

J Am Soc Nephrol. 2019 Oct 11. pii: ASN.2019050545. doi: 10.1681/ASN.2019050545. [Epub ahead of print]

PMID:
31604808
19.

Importance of high-quality ANA testing for SLE classification. Response to: 'Role of ANA testing in the classification of patients with systemic lupus erythematosus' by Pisetsky et al.

Aringer M, Costenbader KH, Dörner T, Johnson SR.

Ann Rheum Dis. 2019 Oct 11. pii: annrheumdis-2019-216337. doi: 10.1136/annrheumdis-2019-216337. [Epub ahead of print] No abstract available.

PMID:
31604707
20.

Overlap of systemic lupus erythematosus and myositis is rare in anti-Ku antibody-positive patients.

Ogawa-Momohara M, Muro Y, Akiyama M.

Ann Rheum Dis. 2019 Oct 11. pii: annrheumdis-2019-216375. doi: 10.1136/annrheumdis-2019-216375. [Epub ahead of print] No abstract available.

PMID:
31604706

Supplemental Content

Loading ...
Support Center